DUBLIN, Nov. 7, 2017 /PRNewswire/ -- Allergan plc (NYSE:
AGN), a leading global biopharmaceutical company, today announced
that William Meury, Allergan's Chief
Commercial Officer, will present at the Credit Suisse 26th Annual
Healthcare Conference today, Tuesday,
November 7, 2017 at 9:10 a.m.
MT (11:10 a.m. ET) at The
Phoenician in Scottsdale, Arizona.
The presentation will be webcast live and can be accessed on
Allergan's Investor Relations website at
www.allergan.com/investors. The webcast can also be accessed
through the following URL:
https://cc.talkpoint.com/cred001/110717a_as/?entity=76_NH13G6E
An archived version of the webcast will be available
approximately two hours after the live presentation ends, and can
be accessed at the same location for 180 days.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global
pharmaceutical company and a leader in a new industry model –
Growth Pharma. Allergan is focused on developing,
manufacturing and commercializing branded pharmaceutical, device,
biologic, surgical and regenerative medicine products for patients
around the world.
Allergan markets a portfolio of leading brands and best-in-class
products for the central nervous system, eye care, medical
aesthetics and dermatology, gastroenterology, women's health,
urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, a model of
research and development, which defines our approach to identifying
and developing game-changing ideas and innovation for better
patient care. With this approach, Allergan has built one of the
broadest development pipelines in the pharmaceutical industry with
60+ mid-to-late stage pipeline programs currently in
development.
Allergan's success is powered by our more than 18,000 global
colleagues' commitment to being Bold for Life. Together, we build
bridges, power ideas, act fast and drive results for our customers
and patients around the world by always doing what is right.
With commercial operations in approximately 100 countries,
Allergan is committed to working with physicians, healthcare
providers and patients to deliver innovative and meaningful
treatments that help people around the world live longer, healthier
lives every day.
For more information, visit Allergan's website
at www.Allergan.com.
Forward-Looking Statement
Statements contained in this press release that refer to future
events or other non-historical facts are forward-looking statements
that reflect Allergan's current perspective on existing trends and
information as of the date of this release. Actual results may
differ materially from Allergan's current expectations depending
upon a number of factors affecting Allergan's business. These
factors include, among others, the difficulty of predicting the
timing or outcome of FDA approvals or actions, if any; the impact
of competitive products and pricing; market acceptance of and
continued demand for Allergan's products; difficulties or delays in
manufacturing; and other risks and uncertainties detailed in
Allergan's periodic public filings with the Securities and Exchange
Commission, including but not limited to Allergan's Annual Report
on Form 10-K for the year ended December 31,
2016 and Allergan's Quarterly Report on Form 10-Q for the
period ended September 30, 2017.
Except as expressly required by law, Allergan disclaims any intent
or obligation to update these forward-looking statements.
CONTACTS:
Allergan:
Investors:
Daphne Karydas
(862) 261-8006
Karina Calzadilla
(862) 261-7328
Media:
Mark Marmur
(862) 261-7558
View original content with
multimedia:http://www.prnewswire.com/news-releases/allergan-to-present-at-credit-suisse-26th-annual-healthcare-conference-300550493.html
SOURCE Allergan plc